CSIMarket
 


Kymera Therapeutics Inc   (KYMR)
Other Ticker:  
 
 

Kymera Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics



KYMR Asset Turnover Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
Y / Y Asset Change 73.16 % 12.67 % 15.58 % 26.63 % -
Y / Y Revenue Change -48.43 % -38.43 % - 39.93 % -
Asset Turnover Ratio (TTM) 0.08 0.11 0.13 0.08 0.08
Total Ranking # 2929 # 3313 # 3195 # # 3249
Seq. Asset Change 43.7 % -7.04 % -12.36 % 47.9 % -6.49 %
Seq. Revenue Change -17.05 % 19.66 % - 9.81 % -


Asset Turnover Ratio Comment
Due to detoriation in revenue of -48.43 % in the third quarter 2022 year on year. Kymera Therapeutics Inc 's asset turnover ratio fell to 0.08 below company average.

Within Healthcare sector 506 other companies have achieved higher asset turnover ratio than Kymera Therapeutics Inc . While Kymera Therapeutics Inc 's asset turnover ratio total ranking has impoved so far to 2929, from total ranking in previous quarter at 3313.

What is Asset Turnover Ratio?
What is Kymera Therapeutics Inc Market Share?

Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 115
Healthcare Sector # 507
Overall Market # 2919

Asset Turnover Ratio Statistics
High Average Low
0.13 0.1 0.08
(Mar 31 2022)   (Jun 30 2021)







Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2022, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2022 Assets at quarter ending Sep 30 2022
Bionik Laboratories Corp   0.18 $ 1.151  Millions$ 6.243  Millions
Rvl Pharmaceuticals Plc  0.18 $ 26.208  Millions$ 142.291  Millions
Morphic Holding inc   0.18 $ 74.230  Millions$ 406.605  Millions
Revance Therapeutics Inc   0.18 $ 108.594  Millions$ 611.046  Millions
Eyepoint Pharmaceuticals Inc   0.18 $ 42.415  Millions$ 240.463  Millions
Evoke Pharma Inc   0.17 $ 2.073  Millions$ 11.854  Millions
Fibrogen Inc   0.17 $ 122.911  Millions$ 703.845  Millions
Sangamo Therapeutics Inc   0.17 $ 112.055  Millions$ 646.818  Millions
Atara Biotherapeutics Inc   0.17 $ 70.900  Millions$ 417.461  Millions
Mirum Pharmaceuticals Inc   0.17 $ 52.294  Millions$ 308.595  Millions
Cytokinetics Incorporated  0.17 $ 148.231  Millions$ 886.313  Millions
Arbutus Biopharma Corp  0.17 $ 35.980  Millions$ 215.250  Millions
Delcath Systems Inc   0.16 $ 4.190  Millions$ 25.433  Millions
Inspiremd Inc   0.16 $ 5.551  Millions$ 33.928  Millions
Beigene Ltd   0.16 $ 1,249.805  Millions$ 7,692.889  Millions
Yumanity Therapeutics Inc   0.16 $ 4.845  Millions$ 29.885  Millions
Ngm Biopharmaceuticals Inc   0.16 $ 58.111  Millions$ 358.849  Millions
Exicure Inc   0.16 $ 6.806  Millions$ 43.165  Millions
Biocorrx Inc   0.16 $ 0.145  Millions$ 0.918  Millions
Omnia Wellness Inc  0.15 $ 0.353  Millions$ 2.288  Millions
Isoray Inc   0.15 $ 9.948  Millions$ 65.086  Millions
Alector Inc   0.15 $ 133.171  Millions$ 873.956  Millions
Meiragtx Holdings Plc  0.15 $ 44.106  Millions$ 290.433  Millions
Lifestance Health Group Inc   0.15 $ 295.798  Millions$ 1,958.459  Millions
Arcturus Therapeutics Holdings Inc   0.15 $ 51.500  Millions$ 341.361  Millions
Nutriband Inc   0.15 $ 1.835  Millions$ 12.367  Millions
Histogen Inc   0.15 $ 3.770  Millions$ 25.494  Millions
Aquestive Therapeutics Inc   0.15 $ 8.366  Millions$ 56.669  Millions
Capstone Companies Inc   0.15 $ 0.522  Millions$ 3.536  Millions
Novan Inc   0.15 $ 13.856  Millions$ 94.668  Millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NWPP's Profile

Stock Price

NWPP's Financials

Business Description

Fundamentals

Charts & Quotes

NWPP's News

Suppliers

NWPP's Competitors

Customers & Markets

Economic Indicators

NWPP's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071